The promise of precision oncology
brought to life for patients
Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives.
Our novel therapies are designed to selectively target cancer cells, while moving the field forward in areas with the highest unmet needs. Just as vital to our mission, we’re investigating these therapies in combination with standards of care, forging new paths with the goal of giving patients a better chance for durable remissions.
We Are Kura
What pharma can teach biotech about the life cycle management of a drug
/in CurrentsNavigating dose optimization requirements as a small biotech
/in CurrentsLiquid Biopsies Guide the Development of Cancer Drugs
/in CurrentsLiquid Biopsies Guide the Development of Cancer Drugs
Fierce Biotech: FDA’s renewed focus on oncology dosing spooks investors, but companies say they’re ready
/in CurrentsESMO: Tipifarnib demonstrates encouraging efficacy in patients with recurrent and/or metastatic hnscc with hras mutations
/in CurrentsJournal of Clinical Oncology: Is This the Dawn of Precision Oncology in Head and Neck Cancer?
/in Currents